Department of Neurodegeneration, UCL Queen Square Institute of Neurology, Department of Neurology, The National Hospital for Neurology and Neurosurgery; Moorfields Eye Hospital, London, United Kingdom.
Amsterdam UMC, Neuro-ophthalmology Expertise Centre, NL, US.
Asia Pac J Ophthalmol (Phila). 2022;11(2):196-207. doi: 10.1097/APO.0000000000000519.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic created a unique opportunity to study the effects of infection and vaccination on disease. The year 2020 was dominated by infection and its consequences. The year 2021 was dominated by vaccination and its consequences. It will still take several years for full maturation of databases required for robust epidemiological studies. Therefore, this review on the implications for neuro-ophthalmology draws on resources presently available including reported adverse reactions to vaccination. Illustrative clinical cases are presented.The spectrum of pathology following infection with SARS-CoV-2 falls into 4 main categories: autoimmune, vascular, sequelae of brain damage, and miscellaneous. This review is exhaustive, but the most common conditions discussed relate to headaches and associated symptoms; vertigo, diplopia, and nystagmus; vascular complications of the eye and brain; cranial nerve (mono-)neuropathies; photophobia, ocular discomfort, and optic neuritis. Of the 36 main adverse reactions reviewed, vaccine-induced immune thrombotic thrombocytopenia is a novel complication requiring specific hematological management. Updated diagnostic criteria are summarized. It is relevant to remember taking a medication history because of side effects and to recognize the relevance of comorbidities. The clinical assessment can frequently be performed virtually. Consensus recommendations on telemedicine and the virtual assessment are summarized in a practical and compressed format.The review concludes with an epidemiological tetralogy to interrogate, in future studies, associations with (1) SARS-CoV-2 pandemic infection, (2) SARS-CoV-2 worldwide vaccination, and (3) the possibility of a rebound effect of infections in the pandemic aftermath.
严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 大流行为研究感染和接种疫苗对疾病的影响提供了一个独特的机会。2020 年主要受感染及其后果的影响。2021 年主要受疫苗接种及其后果的影响。要形成用于进行稳健的流行病学研究的完整数据库,还需要数年时间。因此,本篇关于神经眼科学影响的综述借鉴了目前现有的资源,包括疫苗接种的不良反应报告。文中呈现了说明性的临床病例。感染 SARS-CoV-2 后的病理谱分为 4 个主要类别:自身免疫、血管、脑损伤后遗症和其他。本综述详尽无遗,但讨论最多的常见病症与头痛和相关症状、眩晕、复视和眼球震颤、眼和脑的血管并发症、颅神经(单)神经病、畏光、眼部不适和视神经炎有关。在综述的 36 种主要不良反应中,疫苗引起的免疫性血栓性血小板减少症是一种需要特殊血液学管理的新型并发症。总结了更新的诊断标准。由于副作用而记住用药史并识别出合并症的相关性是很重要的。临床评估通常可以通过虚拟方式进行。总结了远程医疗和虚拟评估的共识建议,以简洁实用的格式呈现。该综述以流行病学四联症结尾,以在未来的研究中探讨(1)SARS-CoV-2 大流行感染、(2)SARS-CoV-2 全球疫苗接种、以及(3)大流行后感染反弹的可能性之间的关联。